FDA set to authorize Pfizer-BioNTech COVID-19 vaccine for adolescents early next week

 The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and BioNTech SE's COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency's plans. 

https://www.marketscreener.com/news/latest/FDA-set-to-authorize-Pfizer-BioNTech-COVID-19-vaccine-for-adolescents-early-next-week-NYT--33145669/